Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 21Lymphoid 19Other hematologic neoplasm 16Genitourinary 7Thoracic 6Other solid neoplasm 6Dermatologic 6Breast 5Myeloid 3Head & Neck 3Gastrointestinal 3Tumor-Agnostic 2Sarcoma 2CNS 2

Conditions

Sarcoma 2Kidney Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 144Doxorubicin 112Temozolomide 110Cyclophosphamide 110Filgrastim 79Ifosfamide 70Imatinib Mesylate 69Etoposide 69Bevacizumab 55Vincristine 51Gemcitabine 50Peripheral Blood Stem Cell Transplantation 47Irinotecan 43Methotrexate 39Cisplatin 36Carboplatin 36Radiation 35fludarabine phosphate 34Busulfan 34pazopanib 32Sirolimus 30Melphalan 30Trabectedin 29Docetaxel 27Chemotherapy, Adjuvant 27Cyclosporine 25Carmustine 25sargramostim 24Surgical Procedures, Operative 23Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Panobinostat × Sarcoma × Clear all
NCT01005797 2017-03-03

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Medical University of South Carolina

Phase 1 Completed
38 enrolled
GenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Sarcoma

NCT01136499 2013-03-06

ESTIM-LBH

Centre Leon Berard

Phase 2 Completed
53 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡